ΑρΑ«ΚΣΖ΅

Meeting Coverage

EASL

European Association for the Study of the Liver

Testosterone Prodrug Improves Muscle Mass, Encephalopathy in Men With Cirrhosis

Androgen precursor may help cirrhosis-related sarcopenia

EASL over a photo of Milano Convention Centre in Milan, Italy

Latest EASL Meeting Coverage

Rifaximin Prophylaxis Fails for Bacterial Peritonitis in Cirrhotic Patients

"Is it time to say primary prophylaxis is dead?" one expert asks

June 11, 2024
Patients With Severe ACLF on Liver Transplant Waitlists Face High Mortality Rates

Urgent need for organ allocation system reform, researchers say

June 9, 2024
Weight Loss/Diabetes Drug Has Positive Treatment Effect on MASH

GLP-1/GIP agonist also improved fibrosis biomarkers, liver fat, and stiffness in phase II trial

June 8, 2024
Novel Glucagon/GLP-1 Receptor Dual Agonist Improved MASH in Phase II Study

Effects may be related to weight loss, not changes in fibrogenesis, expert suggests

June 7, 2024
Novel Intelligent Liver Function Test Platform Improves Liver Disease Diagnosis

iLFT is now an essential, highly utilized tool at one U.K. primary care system

June 7, 2024
Bulevirtide/Pegylated Interferon Combo Beats Monotherapy for Chronic Hepatitis D

Combo therapies for HDV with drugs other than pegylated interferon would be better, expert says

June 6, 2024
Tenofovir Alafenamide Remains the Most Effective Treatment for Chronic HBV

Persistent viral suppression in most patients, even after 8 years

June 26, 2023
Can AI Help Determine If Liver Cancer Will Respond to Standard Treatment?

Early model suggests a way to predict progression-free survival

June 26, 2023
Fecal Matter Transplant Shows Promise in Cirrhosis

Pilot trial demonstrates that FMT can boost gut health, prevent serious infections

June 25, 2023
Novel Agent Leads to Fibrosis Improvement in NASH

Phase IIb ENLIVEN trial saw success with various doses of pegozafermin

June 24, 2023
Ukraine's Mobile Medical Teams Duck Rockets

Public health expert describes pivot to provide medical aid in war-torn Ukraine

June 23, 2023
Antiviral Offers 'Glimmer of Hope' in Chronic Hepatitis D

At 48 weeks, bulevirtide led to undetectable HDV RNA, normalization of ALT in up to 48%

June 23, 2023
'Game Changer' in NASH: Resmetirom Hits Endpoints in Pivotal Study

Investigational drug more likely to resolve severe form of fatty liver disease, improve fibrosis

June 22, 2023
EASL Roundup: Path to 'Cure' in Hep B? Low-Carb, High-Fat Diet for NAFLD With T2D

Noteworthy research from the European Association for the Study of the Liver annual meeting

June 29, 2022